Antibodies; a Component of the Immune System That Recognizes Foreign Substances and Neutralize Them
Antibodies |
Antibodies are proteins produced by the
immune system in response to infection. They are an important part of the
body's defense system as they help destroy disease-causing organisms, such as
bacteria or viruses, and prevent them from infecting human cells. There are
five types of heavy chain constant regions in antibodies (immunoglobulin) and
according to these types, they are classified into Immunoglobulin G (IgG), Immunoglobulin
M (IgM), Immunoglobulin A (IgA), Immunoglobulin D (IgD), and Immunoglobulin E (IgE).
IgG is a most common type of antibody in
the blood and other body fluids. Antibodies
protect people from infection by remembering which germs people have been
exposed to in the past. If those germs come back, the immune system attack
them. By binding many kinds of pathogens such as viruses, bacteria, and fungi,
IgG protects the body from infection. Immunoglobulin M (IgM) not only serves as
the first line of host defense against infections but also plays an important
role in immune regulation and immunological tolerance.
IgM is the first antibody isotype to appear
during evolution, ontogeny, and immune responses. IgA is the first line of
defence in the resistance against infection, via inhibiting bacterial and viral
adhesion to epithelial cells and by neutralization of bacterial toxins and
virus, both extra- and intracellularly. While, IgE is an antibody that is
produced by the body's immune system in response to a perceived threat. Antibodies
are proteins that the body’s immune system produces to recognize foreign
objects. They recognize specific molecule on a pathogen called an antigen.
These antibodies protect us from harmful organisms and diseases.
Antibody is a protein component of the
immune system that circulates in the blood, recognizes foreign substances, such
as bacteria and viruses, and helps neutralize them. Antibodies attach
themselves to the foreign substance, allowing other immune system cells to
attack and destroy the substance. Because the Omicron has become the dominant
variant in the U.S., the National Institute of Health recommends against using
casirivimab plus imdevimab, bamlanivimab plus etesevimab, or sotrovimab
(monoclonal antibodies) for the treatment of COVID-19.
Comments
Post a Comment